These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11334124

  • 1. Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler.
    Goldberg J, Freund E, Beckers B, Hinzmann R.
    Eur Respir J; 2001 Feb; 17(2):225-32. PubMed ID: 11334124
    [Abstract] [Full Text] [Related]

  • 2. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
    Kunkel G, Magnussen H, Bergmann K, Juergens UR, de Mey C, Freund E, Hinzmann R, Beckers B.
    Respiration; 2000 Feb; 67(3):306-14. PubMed ID: 10867600
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A, Jeena PM, Soemantri PA, Vertruyen A, Schmidt P, Gerken F, Razzouk H.
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [Abstract] [Full Text] [Related]

  • 4. Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.
    Kilfeather SA, Ponitz HH, Beck E, Schmidt P, Lee A, Bowen I, Hesse Ch.
    Respir Med; 2004 May; 98(5):387-97. PubMed ID: 15139567
    [Abstract] [Full Text] [Related]

  • 5. Delivery of fenoterol via Respimat, a novel 'soft mist' inhaler. a randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients.
    van Noord JA, Smeets JJ, Creemers JP, Greefhorst LP, Dewberry H, Cornelissen PJ.
    Respiration; 2000 May; 67(6):672-8. PubMed ID: 11124651
    [Abstract] [Full Text] [Related]

  • 6. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F, Hodder R, Bateman ED.
    Drugs; 2004 May; 64(15):1671-82. PubMed ID: 15257628
    [Abstract] [Full Text] [Related]

  • 7. Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD.
    Iacono P, Velicitat P, Guemas E, Leclerc V, Thébault JJ.
    Respir Med; 2000 May; 94(5):490-5. PubMed ID: 10868713
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.
    Pavia D, Moonen D.
    J Aerosol Med; 1999 May; 12 Suppl 1():S33-9. PubMed ID: 10623340
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH, Luursema PB, Sips AP, Beumer HM, Wald FD, Cornelissen PJ.
    Respiration; 1992 May; 59(6):322-6. PubMed ID: 1488568
    [Abstract] [Full Text] [Related]

  • 11. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P, Hederer B, Austen G, Dewberry H, Meyer T.
    Int J Chron Obstruct Pulmon Dis; 2008 May; 3(4):763-70. PubMed ID: 19281091
    [Abstract] [Full Text] [Related]

  • 12. Fenoterol delivery by Respimat soft mist inhaler versus CFC metered dose inhaler: cumulative dose-response study in asthma patients.
    Vincken W, Dewberry H, Moonen D.
    J Asthma; 2003 Sep; 40(6):721-30. PubMed ID: 14580004
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC, Combivent Respimat Inhaler Study Group.
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G, Hofbauer P, Cannizzaro G, Iacono P, Wald F.
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [Abstract] [Full Text] [Related]

  • 15. Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction.
    Schürmann W, Schmidtmann S, Moroni P, Massey D, Qidan M.
    Treat Respir Med; 2005 Apr; 4(1):53-61. PubMed ID: 15725050
    [Abstract] [Full Text] [Related]

  • 16. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [Abstract] [Full Text] [Related]

  • 17. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E.
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [Abstract] [Full Text] [Related]

  • 18. Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
    Goldberg J, Böhning W, Schmidt P, Freund E.
    Respir Med; 2000 Oct; 94(10):948-53. PubMed ID: 11059947
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat((R)) Soft Misttrade mark Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma.
    Vincken W, Bantje T, Middle MV, Gerken F, Moonen D.
    Clin Drug Investig; 2004 Oct; 24(1):17-28. PubMed ID: 17516687
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF, Wise R, Busse WW, Garfinkel S, Zubek VB, Ghafouri M, Manuel RC, Schlenker-Herceg R, Bleecker ER.
    BMC Pulm Med; 2016 Apr 30; 16(1):65. PubMed ID: 27130202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.